Pharmafile Logo
Pharmafocus logo
Advanced Search

Clover reveals positive data from Phase II/III COVID-19 vaccine trial

January 21, 2022
Medical Communications

Clover Biopharmaceuticals has announced that final efficacy data from SPECTRA, a global Phase II/III clinical trial into its COVID-19 vaccine …

News

LUMAKRAS (sotorasib) receives approval in Japan for lung cancer patients

January 20, 2022
Business Services

Amgen has announced that LUMAKRAS received approval in Japan for the treatment of patients with KRAS G12C-mutated advanced non-small cell …

News

All Plan B restrictions to end in England

January 20, 2022
Business Services

Prime Minister Boris Johnson has announced that England’s Plan B measures are to end from 26 January. This will include …

News

1.27 million deaths a year attributable to antimicrobial resistance

January 20, 2022
Business Services

The Global Research on Antimicrobial Resistance (GRAM) paper has revealed the true scale of antibiotic resistance in Western Europe, and …

News

Vaccine alliance Gavi says that additional $5.2bn needed to ensure supply

January 20, 2022
Business Services

The chairman of the Gavi vaccine alliance, Jose Manuel Barroso, has said that an additional $5.2 billion is required to …

News

Engitix and Dompé collaboration for fibrosis and cancer AI drug discovery

January 19, 2022
Research and Development

Engitix has announced the close of its $54m Series A financing, as well as a strategic collaboration, with Dompé farmaceutici …

News
e-6olmfwuay74lr

MHRA license Jyseleca for treatment of ulcerative colitis

January 19, 2022
Research and Development

Galapagos NV, the Belgian parent company of Galapagos Biotech Ltd, have announced that Jyseleca® (filgotinib 200mg tablets) has been granted …

News

UK launch of generic lenalidomide for myeloma

January 19, 2022
Research and Development

Accord Healthcare have announced the UK launch of generic lenalidomide, available for the treatment of adult patients with multiple myeloma, …

News

SMC accepts first-line treatment for lung cancer

January 19, 2022
Research and Development

The SMC has accepted AstraZeneca’s Tagrisso (osimertinib) for use as monotherapy for the first-line treatment of adult patients with locally …

News

Julie Beeso joins Envision Pharma Group as new Global Director

January 18, 2022
Manufacturing and Production

Envision Pharma Group has appointed Julie Beeso as its Global Director, Professional Development and Engagement. Julie has worked for almost …

Appointment
mario_torchia_ist

Mario Torchia appointed as new Vice President of Sales & Marketing at InSilicoTrials

January 18, 2022
Manufacturing and Production

InSilicoTrials, a leader in simulation software solutions for healthcare, has announced Mario Torchia’s appointment. Torchia recently led the Sales Strategy …

Appointment

Enhertu granted priority review in US for patients with HER2-positive metastatic breast cancer

January 18, 2022
Manufacturing and Production

Enhertu, manufactured by AstraZeneca and Daiichi Sankyo, has been accepted for the treatment of adult patients in the US with …

News

SMC accept Enhertu for the treatment of HER2 positive metastatic breast cancer

January 18, 2022
Manufacturing and Production

Daiichi Sankyo and AstraZeneca have announced that the SMC has accepted Enhertu® for use within NHS Scotland for the treatment …

News
andrei_r_-_shutterstock_1935537274_720

Almirall and IRB Barcelona research for skin disease therapeutics discovery

January 18, 2022
Manufacturing and Production

Almirall and IRB Barcelona (the Institute for Research in Biomedicine) have announced a research collaboration to identify the new oral …

News

Abbisko Therapeutics collaborates with Lilly to discover novel molecules

January 18, 2022
Manufacturing and Production

Abbisko Therapeutics announced that it has entered into a partnership and exclusive licensing agreement with Eli Lilly and Company. This …

News

Neurimmune and Ono Pharmaceutical collaborate to research neurodegenerative diseases

January 17, 2022
Sales and Marketing

Neurimmune AG has signed an expanded drug discovery collaboration agreement with Ono Pharmaceutical. The companies aim to focus on creating …

News

NICE draft guidance recommends new treatment for rare liver condition

January 17, 2022
Sales and Marketing

On Friday 14 January, NICE published a final draft Highly Specialised Technologies guidance, recommending odevixibat in line with its marketing …

News

FDA places Alzheimer’s therapeutic IND Application on hold

January 17, 2022
Sales and Marketing

The FDA has placed a hold on the Investigational New Drug (IND) application for DNL919, indicating they will provide an …

News

COVID-19 self-isolation cut to five full days in England

January 17, 2022
Sales and Marketing

The minimum self-isolation period for people testing positive for COVID-19 in England has been cut from seven days to five …

News

AstraZeneca and Scorpion strike $1.5bn deal against hard-to-treat proteins

January 14, 2022
Medical Communications

AstraZeneca and Scorpion have partnered to develop precision medicines against previously hard-to-target cancer proteins. The collaboration, valued at more than …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025